These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 6742803)

  • 41. In vitro anti-Vibrio cholerae activity of essential oil from Lepechinia caulescens.
    Acevedo JG; López JL; Cortés AM; Bores AM; Cortés GM; Castro IP
    Fitoterapia; 2005 Jan; 76(1):104-7. PubMed ID: 15664471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Cholera in Guinea: the 1994-1995 epidemic].
    Boiro MY; Lama N; Barry M; Diallo R; Morillon M
    Med Trop (Mars); 1999; 59(3):303-6. PubMed ID: 10701212
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multidrug resistance in Vibrio cholerae.
    Anand VK; Arora S; Patwari AK; Agarwal GD; Dewan N
    Indian Pediatr; 1996 Sep; 33(9):774-7. PubMed ID: 9057408
    [No Abstract]   [Full Text] [Related]  

  • 44. [Is Vibrio cholerae serotype 0139 a potential cause of a new pandemic?].
    Dalsgaard DA; Larsen JL
    Ugeskr Laeger; 1995 Jan; 157(3):280-3. PubMed ID: 7846774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An epidemic of Vibrio cholerae el tor Inaba resistant to several antibiotics with a conjugative group C plasmid coding for type II dihydrofolate reductase in Thailand.
    Tabtieng R; Wattanasri S; Echeverria P; Seriwatana J; Bodhidatta L; Chatkaeomorakot A; Rowe B
    Am J Trop Med Hyg; 1989 Dec; 41(6):680-6. PubMed ID: 2641646
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Antibiotic resistance pattern of 24, 526 strains of Vibrio cholerae O1 isolated in Mexico from 1991 to 1993].
    Giono-Cerezo S; Zárate A; Gutiérrez L; Valdespino JL
    Rev Latinoam Microbiol; 1994; 36(4):257-62. PubMed ID: 7701135
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessing clonality of Vibrio cholerae strains isolated during four consecutive years (2004 - 2007) in Iran.
    Bakhshi B; Pourshafie MR
    Scand J Infect Dis; 2009; 41(4):256-62. PubMed ID: 19253091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Emergence of Vibrio cholerae O1 biotype El Tor serotype Inaba causing outbreaks of cholera in Orissa, India.
    Pal BB; Khuntia HK; Samal SK; Das SS; Chhotray GP
    Jpn J Infect Dis; 2006 Aug; 59(4):266-9. PubMed ID: 16936349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Bacteriological aspects of cholera in Benin (epidemic of 1991)].
    Anagonou SY; Josse R; Foundohou J; Helynck B; Massougbodji A; Sadeler BC
    Bull Soc Pathol Exot; 1993; 86(5):333-5. PubMed ID: 8124099
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Vibrion variability under the action of antibiotics].
    Mikhaĭlova RS; Bykova ZA
    Antibiotiki; 1978 Feb; 23(2):163-8. PubMed ID: 343710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of a clinical Vibrio cholerae O139 isolate from Mexico.
    Parveen S; Farrah SR; Gonzalez-Bonilla C; Zamudio AV; Tamplin ML
    Can J Microbiol; 2003 Jan; 49(1):65-70. PubMed ID: 12674350
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Possibility of quickly determining the sensitivity of cholera vibrio to antibiotics using erythrocytic diagnosticum].
    Roshchin VV; Suleĭmenov BM; Semiotrochev VL
    Lab Delo; 1971; 8():501-2. PubMed ID: 4114051
    [No Abstract]   [Full Text] [Related]  

  • 53. Endemic cholera in Delhi, 1995: analysis of data from a sentinel centre.
    Singh J; Sachdeva V; Bhatia R; Bora D; Jain DC; Sokhey J
    J Diarrhoeal Dis Res; 1998 Jun; 16(2):66-73. PubMed ID: 9805411
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 'Gastro' of Mirpur Khas (Sindh) is resolved.
    Hannan A; Raja M; Arshad MU; Absar M
    J Ayub Med Coll Abbottabad; 2008; 20(1):10-2. PubMed ID: 19024176
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of plasmid-mediated resistance in Vibrio cholerae during treatment with trimethoprim-sulfamethoxazole.
    Dupont MJ; Jouvenot M; Couetdic G; Michel-Briand Y
    Antimicrob Agents Chemother; 1985 Feb; 27(2):280-1. PubMed ID: 3885851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Sensitivity to antibiotics of El Tor cholera vibrions].
    Shvetsov RI; Ganin VS; Maramovich AS; Veĭde AA
    Antibiotiki; 1976 Sep; 21(9):816-7. PubMed ID: 999265
    [No Abstract]   [Full Text] [Related]  

  • 57. Class 1 integron-borne, multiple-antibiotic resistance encoded by a 150-kilobase conjugative plasmid in epidemic vibrio cholerae O1 strains isolated in Guinea-Bissau.
    Dalsgaard A; Forslund A; Petersen A; Brown DJ; Dias F; Monteiro S; Molbak K; Aaby P; Rodrigues A; Sandström A
    J Clin Microbiol; 2000 Oct; 38(10):3774-9. PubMed ID: 11015401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Experimental resistance of Vibrio cholerae el tor to nalidixic acid and fluoroquinolones].
    Ryzhko IV; Tsuraeva RI; Lomov IuM; Shut'ko AG; Mishan'kin BN; Koroleva NS; Samokhodkina ED; Shcherbaniuk AI
    Antibiot Khimioter; 2000; 45(9):7-12. PubMed ID: 11057367
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of different antibiotics in inhibiting colonization of Vibrio cholerae O1 and O139 in the rabbit intestine.
    Chakrabarti MK; Bhattacharya MK; Bhattacharya J; Bhattacharya SK; Mahalanabis D
    Chemotherapy; 1998; 44(2):108-11. PubMed ID: 9551241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Computer based screening for novel inhibitors against Vibrio cholerae using NCI diversity set-II: an alternative approach by targeting transcriptional activator ToxT.
    Mondal SI; Khadka B; Akter A; Roy PK; Sultana R
    Interdiscip Sci; 2014 Jun; 6(2):108-17. PubMed ID: 25172449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.